Tomsk researchers developed new nanosilver catalysts

10 August 2018

GMP News

The Tomsk Polytechnic University (TPU) research team proposed to use catalysts based on silver nanoparticles in liquid-phase oxidation of alcohols. This will allow making the process of alcohol oxidation more ecological and cost-effective, comparing with more traditional high-temperature gas-phase oxidation or with toxic reagents.

In the article, published in the journal Fuel, the researchers proved the possibility to use these catalysts based on silver, on the example of the oxidation of octanol and betulin. The derivatives of these substances are valuable products for the chemical, pharmaceutical, and cosmetic industries.

“In the organic synthesis, the alcohol oxidation in the liquid phase is a more green approach, comparing to that in the gas phase. Firstly, it proceeds at lower temperatures, making it less energy-consuming. Secondly, there are no products of complete oxidation, i.e., water and CO2, whose formation indicates a decrease in the reaction selectivity and a decrease in the output of the target product as well”, explained Ekaterina Kolobova, one of the authors of the article, a senior researcher of the Research School of Chemistry & Applied Biomedical Sciences.

Scientists pay particular attention to the use of gold and metals of the platinum group as catalysts in such processes. In the studies TPU scholars used catalysts that are a substrate of titanium oxide. It can be pure or modified by other elements, for example, cerium oxide with silver nanoparticles deposited on its surface.

Using these recently developed nanosilver catalysts the research team has succeeded in obtaining one of the oxo-derivatives of betulin – betulon under conditions close to green chemistry. It means at a temperature below 150°C and avoiding alkaline and initiating additives, which application can entail the formation of undesirable and toxic waste.


Previous publication Next publication

Media Center

  • 19 September 2018

    Russia approves new state strategy for pharmaceutical industry

    A new state strategy for the development of the domestic pharmaceutical industry, known as "Strategy for the development of the pharmaceutical industry of Russia until 2030," has been recently approved by the Russian Ministry of Industry and Trade, with the aim to bring the Russian pharmaceutical production to a new level.

  • 18 September 2018

    The Ministry of Health of the Russian Federation improves patent protection law

    The Ministry of Health of Russia has published a notification on the development of amendments to Federal Law No. 61 of 12.04.2010 “On circulation of medicinal products”, designed to synchronize it with regulatory acts of the Eurasian Economic Union. The procedure for registration of the medicinal product will be corrected.

  • 17 September 2018

    GlobalData published new report on the Top 25 pharma companies

    The performance highlights of the Top 25 publicly traded global pharmaceutical companies by Market Cap (Mcap) for the quarter ended June 30, 2018 (Q2), compared to the quarter ended March 31, 2018 (Q1), have been analyzed in the latest research from GlobalData, a leading data and analytics company.

  • 14 September 2018

    US scientists conduct clinical trial of influenza vaccine with imiquimod

    A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a “pre-pandemic” influenza vaccine is underway at Baylor College of Medicine in Houston (USA). Investigators are evaluating whether imiquimod cream, which is commonly used to treat genital warts and certain skin cancers, can boost the body’s immune response to an H5N1 influenza vaccine. The trial is enrolling 50 healthy adults ages 18-50 years. 

Read more